Procedure guidance for medicines funded through the Life Saving Drugs Program (LSDP)

This guidance document outlines our process and associated timelines to consider medicines seeking funding through the LSDP. It helps sponsors to prepare an application to make an ultra-rare disease medicine available on the LSDP.

Downloads

Procedure guidance for medicines funded through the Life Saving Drugs Program (LSDP)

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Guideline
Audience:
Health sector
Language:
English
Description:

This guidance provides:

  • support for sponsors seeking to prepare applications to the LSDP
  • an explanation of procedures for considering new medicines seeking listing on the LSDP
  • information for consumers relating to the decision-making process for LSDP medicines, and how individuals can be involved in the process
  • an explanation of procedures for reviews of LSDP medicines
  • an overview of procedures for implementing a Government decision to make a medicine available through the LSDP.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.